Stanmax Laboratories Private Limited - Company Profile

It is a pharma private limited company based in Hyderabad, Telangana, India, established in 1996.
1996 Hyderabad, Telangana, India Active
Last Updated:
Access Report
About Stanmax Laboratories Private Limited

Stanmax Laboratories Private Limited, a active private limited company, was established on 02 December 1996 in Hyderabad, Telangana, India. Engaging in animal pharmaceuticals & healthcare within the manufacturing sector, it holds CIN: U24235TG1996PTC025837. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹2.60 Cr and a paid-up capital of ₹2.33 Cr.

It upholds a compliant status. Employing 27 professional, Its leadership includes Ghanukota Rupa (Director), Ghanukota Sravan Kumar (Director), Shashi Ramu Gunukota (Director). Past directors included Dasari Sridhar, Ghanukota Sravan Kumar, Balguri Anuradha. It holds ₹9.85 Cr open charges and no settled loans. Its latest AGM occurred on 27 September 2025, with the balance sheet filed on 31 March 2025. It is based at 2-24-86/3/1,Laxmi Narayana Colony, Uppal, Hyderabad, Telangana, 500039.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24235TG1996PTC025837

  • Registration Number

    025837

  • Incorporation Date

    02 December 1996

  • Authorized Capital

    ₹2.60 Cr

  • Paid-Up Capital

    ₹2.33 Cr

  • ROC Code

    Roc Hyderabad

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 2.60 Cr
  • Paid Up Capital ₹ 2.33 Cr
  • Company Age 29 Year, 7 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 9.85 Cr
  • Revenue Growth **** -24.44%
  • Profit Growth **** 118.89%
  • Ebitda **** 83.54%
  • Net Worth 7.92%
  • Total Assets **** 54.86%
Company report

Stanmax Laboratories Private Limited

Company Report FY 2026-2027

Comprehensive Company Insights

Explore comprehensive insights into Stanmax Laboratories Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Stanmax Laboratories Private Limited?
Current Directors
Name Designation Appointment Date Status
Ghanukota Rupa Director 04 Apr 2007 Current
Ghanukota Sravan Kumar Director 28 Mar 2018 Current
Shashi Ramu Gunukota Director 20 Feb 2025 Current
Srija Ghanukota Director 20 Feb 2025 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 16 Aug 2018 Past
Pramod Abcsdd Additional Director 28 Sep 2018 Past
Pramod Abcsdd Director 18 Oct 2017 Past
Pramod Abcsdd Director 16 Aug 2018 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Stanmax Laboratories.

Stanmax Laboratories Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 24.44% decrease. The company also saw a substantial improvement in profitability, with a 118.89% increase in profit. The company's net worth moved up by a moderate rise of 7.92%.

Stanmax Laboratories revenue growth over time
Stanmax Laboratories profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 -24.44%
*******
*******
*******
*******
Revenue from Operations
*******
 -24.65%
*******
*******
*******
*******
Total Assets
*******
 54.86%
*******
*******
*******
*******
Profit or Loss
*******
 118.89%
*******
*******
*******
*******
Net Worth
*******
 7.92%
*******
*******
*******
*******
EBITDA
*******
 83.54%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Stanmax Laboratories?

Unlock access to Stanmax Laboratories's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹98,500,000.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions
  • Sidbi : 7.50 Cr
  • Axis Bank Limited : 1.00 Cr
  • Indusind Bank Limited : 0.55 Cr
  • Hdfc Bank Limited : 0.50 Cr
  • Canara Bank : 0.30 Cr
Latest Charge Details
Date Lender Amount Status
24 Mar 2025 Sidbi ₹7.50 Cr Open
25 May 2021 Axis Bank Limited ₹1.00 Cr Open
27 Nov 2015 Hdfc Bank Limited ₹5.00 M Open
29 Sep 2014 Indusind Bank Limited ₹5.50 M Open
30 Jul 2008 Canara Bank ₹3.00 M Open

Explore comprehensive loan charge details -

How Many Employees Work at Stanmax Laboratories?

Stanmax Laboratories has a workforce of 27 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Stanmax Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Stanmax Laboratories's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Stanmax Laboratories
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Stanmax Laboratories Private Limited last Annual general meeting of members was held on 27 Sep 2025 as per latest MCA records. was documented.

  • Balance Sheet

    Stanmax Laboratories Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad. was recorded as a recent event.

  • Charges

    A charge with Sidbi amounted to Rs. 7.50 Cr with Charge ID 101065316 was registered on 24 Mar 2025. was recorded as a recent event.

  • Director Appointment

    The activity Shashi Ramu Gunukota was appointed as a Director was appointed as a Director on 20 Feb 2025 & has been associated with this company since 1 year 4 months . was completed.

  • Director Appointment

    The activity Srija Ghanukota was appointed as a Director was appointed as a Director on 20 Feb 2025 & has been associated with this company since 1 year 4 months . was completed.

  • Charges

    A charge with Axis Bank Limited of Rs. 1.00 Cr registered on 25 May 2021 with Charge ID 100453191 was modified on 23 Mar 2022. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Stanmax Laboratories Private Limited?

The CIN of Stanmax Laboratories Private Limited is U24235TG1996PTC025837.

Where is Stanmax Laboratories Private Limited headquartered?

Stanmax Laboratories Private Limited is headquartered at 2-24-86/3/1,Laxmi Narayana Colony, Uppal, Hyderabad, Telangana, 500039.

When was Stanmax Laboratories Private Limited incorporated?

Stanmax Laboratories Private Limited was incorporated on 02 December 1996.

Who are the current directors of Stanmax Laboratories Private Limited?

The current directors of Stanmax Laboratories Private Limited are

What is the primary industry of Stanmax Laboratories Private Limited?

The primary industry of Stanmax Laboratories Private Limited is Manufacturing.

Is Stanmax Laboratories Private Limited a listed company?

Stanmax Laboratories Private Limited is unlisted.

What is the capital structure of Stanmax Laboratories Private Limited?

The authorized capital of Stanmax Laboratories Private Limited is ₹2.60 Cr, and the paid-up capital is ₹2.33 Cr.

What is the compliance status of Stanmax Laboratories Private Limited?

The compliance status of Stanmax Laboratories Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available